Cargando...
Modern Obesity Pharmacotherapy: Weighing Cardiovascular Risk and Benefit
Obesity is a major correlate of cardiovascular disease. Weight loss improves cardiovascular risk factors and has the potential to improve outcomes. Two drugs, phentermine plus topiramate and lorcaserin, have recently been approved by the US Food and Drug Administration for the indication of obesity;...
Gardado en:
| Publicado en: | Clin Cardiol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley Periodicals, Inc.
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6649490/ https://ncbi.nlm.nih.gov/pubmed/25223901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22304 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|